跳到主要內容

Yonehiro Grant 的 Form 4 申報

Bolt Biotherapeutics, Inc.(BOLT),2026/9/21 申報

申報編號
0001193125-26-396894
申報時間
2026/9/21 18:05 ET
交易日
2026/9/16-9/18
申報延遲
5 天遲報
10b5-1 計畫
沒有勾選

這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $4.38 萬。交易後 5 天才申報,超過 2 個營業日的期限。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Yonehiro GrantCIK 0001428666高階主管(營運長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/9/16Common StockS賣出處分−1,417$3.77F1−$5,347.7629,028直接
2026/9/17Common StockS賣出處分−4,909$3.32F2−$16,289.5324,119直接
2026/9/18Common StockS賣出處分−6,850$3.24F3−$22,169.3417,269直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.60 to $4.14. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F2

Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.22 to $3.67. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)